免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

Brainomix 360 e-CTA

K号: K192692 · 2020-05-28

决定日期2020-05-28
产品代码LLZ
咨询委员会RA
决定实质等同

器械摘要

Brainomix 360 e-CTA is the device name listed in this FDA 510(k) record. The listed applicant is Brainomix Limited. It received FDA 510(k) clearance on 2020-05-28 under 510(k) number K192692. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the Brainomix 360 e-CTA?

Brainomix 360 e-CTA is a medical device that received FDA 510(k) clearance on 2020-05-28. The listed applicant is Brainomix Limited. The 510(k) number is K192692.

When did Brainomix 360 e-CTA receive FDA 510(k) clearance?

Brainomix 360 e-CTA received FDA 510(k) clearance on 2020-05-28, under 510(k) number K192692.

Who is the listed applicant for Brainomix 360 e-CTA?

The FDA 510(k) record lists Brainomix Limited as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Brainomix 360 e-CTA?

The FDA product code for Brainomix 360 e-CTA is LLZ.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

列明Brainomix Limited为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

查看所有 13 个设备 →

相关器械(代码:LLZ)

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑